SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-094415
Filing Date
2022-08-25
Accepted
2022-08-25 16:02:13
Documents
2
Period of Report
2022-08-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2224572-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2224572-1_3seq1.xml 3 2275
2 EXHIBIT 24 tm2224572d1_ex24.htm EX-24 8401
  Complete submission text file 0001104659-22-094415.txt   12211
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVENUE THERAPEUTICS, INC. 1140 AVENUE OF THE AMERICAS, FLOOR 9 NEW YORK NY 10036
Business Address
Jin David (Reporting) CIK: 0001930732 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35366 | Film No.: 221197374